Inhibiting SHH and Gli1 signaling with a small molecule inhibitor in hepatic stellate cells that express high levels of SMO receptor and low levels of SHH ligands, in contrast to cancer cells, which express low levels of SMO and elevated SHH, inhibits proliferation in vivo [535]. Here, SHH is linked to cancer.